Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP-channel hyperinsulinism-Reference-Cited by-同舟云学术

Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP-channel hyperinsulinism

Published:2013-04-06 Issue:6 Volume:78 Page:891-897
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Yorifuji Tohru¹,Kawakita Rie¹,Hosokawa Yuki¹,Fujimaru Rika¹,Matsubara Kousaku²,Aizu Katsuya³,Suzuki Shigeru⁴,Nagasaka Hironori⁵,Nishibori Hironori⁶,Masue Michiya⁷

Affiliation:

1. Department of Pediatric Endocrinology and Metabolism; Children's Medical Center, Osaka City General Hospital; Osaka; Japan

2. Department of Pediatrics; Nishi-Kobe Medical Center; Kobe; Japan

3. Division of Endocrinology and Metabolism; Saitama Children's Medical Center; Saitama; Japan

4. Department of Pediatrics; Asahikawa Medical University; Asahikawa; Japan

5. Department of Pediatrics; Takarazuka City Hospital; Takarazuka; Japan

6. Department of Radiology; Kizawa Memorial Hospital; Minokamo; Japan

7. Department of Pediatrics; Kizawa Memorial Hospital; Minokamo; Japan

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cen.12075/fullpdf

Reference26 articles.

1. Congenital hyperinsulinism: current trends in diagnosis and therapy;Arnoux;Orphanet Journal of Rare Diseases,2011

2. Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1;Macmullen;Diabetes,2011

3. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia;Verkarre;Journal of Clinical Investigation,1998

4. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy;Lonlay;Journal of Clinical Investigation,1997

5. Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism;Damaj;Journal of Clinical Endocrinology and Metabolism,2008

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical management of diazoxide-unresponsive congenital hyperinsulinism: A single-center experience;CLIN PEDIATR ENDOCRI;2024

2. Clinical management of diazoxide-unresponsive congenital hyperinsulinism: A single-center experience;Clinical Pediatric Endocrinology;2024

3. Adjustment of octreotide dose given via insulin pump based on continuous glucose monitoring (CGM) in a child with congenital hyperinsulinism;Journal of Pediatric Endocrinology and Metabolism;2023-05-31

4. Successful Treatment of Congenital Hyperinsulinism Due to KJNJ11 Gene Mutation with Long-Acting Release Octreotide: A Case Report from the Arab Region;Journal of Diabetes and Endocrine Practice;2023-01

5. Somatostatin receptors in congenital hyperinsulinism: Biology to bedside;Frontiers in Endocrinology;2022-09-27